Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.47 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.47 |
| ▸ | CASP6 | P55212 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 8/20 | 0.39 |
| ▸ | CA1 | P00915 | 7/20 | 0.39 |
| ▸ | CA9 | Q16790 | 7/20 | 0.39 |
| ▸ | CA12 | O43570 | 6/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 3/20 | 0.35 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA6 | P23280 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27539058 | 0.78 | GAA (0.62) | NSD2GAAPLCG1DNMT1CASP6 | |
| SCHEMBL27752707 | 0.77 | ALDH1A1 (0.53) | NSD2GAAPLCG1DNMT1CASP6 | |
| SCHEMBL27857014 | 0.77 | NSD2 (0.53) | NSD2GAAPLCG1DNMT1CASP6 | |
| SCHEMBL28177645 | 0.75 | CASP6 (0.51) | NSD2GAAPLCG1DNMT1CASP6 | |
| SCHEMBL1901985 | 0.74 | ALDH1A1 (0.39) | ALDH1A1CA2CA1CA9CA12 | |
| SCHEMBL3136473 | 0.73 | LCK (0.44) | NSD2GAAPLCG1DNMT1CASP6 | |
| SCHEMBL6759012 | 0.73 | ALDH1A1 (0.41) | ALDH1A1TDP1LMNACYP1A2TSHR | |
| SCHEMBL1024318 | 0.73 | ACP1 (0.50) | NSD2GAAPLCG1DNMT1CASP6 | |
| SCHEMBL27732196 | 0.73 | ALDH1A1 (0.57) | NSD2GAAPLCG1DNMT1CASP6 | |
| SCHEMBL11228135 | 0.72 | GAA (0.52) | NSD2GAAPLCG1DNMT1CASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090091325-A1 | METHOD OF DETERMINING DAMAGE TO SKIN | UCL BUSINESS PLC (GB) | 2009-04-09 | — | — | US | claimed |
| WO-2007031777-A2 | METHOD OF DETERMINING DAMAGE TO SKIN | UCL BUSINESS PLC (GB) | 2007-03-22 | — | — | WO | claimed |
| EP-4728554-A1 | SAMPLE DIGESTION FOR MASS SPECTROMETRY | The Rosalind Franklin Institute (GB) | 2026-04-22 | — | — | EP | disclosed |
| WO-2024256790-A1 | SAMPLE DIGESTION FOR MASS SPECTROMETRY | THE ROSALIND FRANKLIN INSTITUTE (GB) | 2024-12-19 | — | — | WO | disclosed |
| WO-2024256813-A1 | SAMPLE DIGESTION FOR MASS SPECTROMETRY | THE ROSALIND FRANKLIN INSTITUTE (GB) | 2024-12-19 | — | — | WO | disclosed |
| US-20090091325-A1 | METHOD OF DETERMINING DAMAGE TO SKIN | UCL BUSINESS PLC (GB) | 2009-04-09 | — | — | US | disclosed |
| WO-2007031777-A2 | METHOD OF DETERMINING DAMAGE TO SKIN | UCL BUSINESS PLC (GB) | 2007-03-22 | — | — | WO | disclosed |
| US-20060133996-A1 | Method and apparatus for determining effectiveness of sunscreens and other skin preparations in shielding human skin from uva radiation | RAFT TRUSTEES LTD. (GB) | 2006-06-22 | — | — | US | disclosed |
| EP-1590003-A1 | METHOD AND APPARATUS FOR DETERMINING EFFECTIVENESS OF SUNSCREENS AND OTHER SKIN PREPARATIONS IN SHIELDING HUMAN SKIN FROM UVA RADIATION | RAFT TRUSTEES LIMITED (GB) | 2005-11-02 | — | — | EP | disclosed |
| WO-2004039414-A1 | METHOD AND APPARATUS FOR DETERMINING EFFECTIVENESS OF SUNSCREENS AND OTHER SKIN PREPARATIONS IN SHIELDING HUMAN SKIN FROM UVA RADIATION | RAFT TRUSTEES LTD. (GB) | 2004-05-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060133996-A1 | Method and apparatus for determining effectiveness of sunscreens and other skin preparations in shielding human skin from uva radiation | MMS19, XPA, ERCC4 | NSD2 2248/4885GAA 2807/4885PLCG1 4324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.